Positioned for growth

Fiscal 2015 was a year that helped set the stage for what Rite Aid executives believe could be a banner fiscal year 2016. Rite Aid is expecting its EnvisionRx acquisition to increase the company’s annual revenues by as much as 17.7%, from $26.5 billion in fiscal 2015 to a projected range of between $30.7 billion and $31.2 billion.

(To view the full Special Report, click here.)



Fiscal 2016 will be remembered for major milestones like the EnvisionRx acquisition and the introduction of its wellness+ with Plenti coalition loyalty program.



But much of the groundwork for EnvisionRx and Plenti was laid in 2015, noted John Standley, Rite Aid chairman and CEO, even as Rite Aid executed against its acquisitions of RediClinic and Health Dialog.



In addition to all of the merger and acquisition activity at the central Pennsylvania retailer, Rite Aid continued its capital commitment to improving its store base with renovations, relocations, remodels and even net new store openings for the first time in five years. Capital expenditures for the year are expected to reach approximately $665 million.